INNO-206

· ImmunityBio, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for INNO-206, covering 2012-02-09 to 2024-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer [Phase 2]

See pricing